Umberto Pensato

@demchuk_andrew receiving WSO award for #stroke service in Seoul, Korea! Andrew and the Calgary Folks mentored hundreds of stroke researchers and clinicians around the world! Well deserved! @WorldStrokeOrg @WorldStrokeEd

"Target Expansion Criteria" for #ICH patients who may benefit from acute therapies in late window. @GreenJournal @NawabiJawed @fmazzacane01 @Libero131087 @RaffaeleOrnello @giovmerl @matpaolucci @m_paciaroni @Simona_Sacco_ @MicheleRomoli @ZiniAndrea @QiLiMD
neurology.org/doi/10.1212/WN…

EVT treatment effect in MeVO #stroke across perfusion mismatch profiles in ESCAPE-MeVO! @JAMANetworkOpen @johanna_ospel @mayank_G0 @draravindganesh @MDStebnerAl @ESOstroke jamanetwork.com/journals/jaman…

The granular HIR was the best performing measure of infarct growth rate in this #stroke study. Published in @_JCBFM, soon to be presented at @WorldStrokeOrg. @Libero131087 @johanna_ospel @bijoymenon @demchuk_andrew phttps://journals.sagepub.com/doi/10.1177/0271678X261492523

Super important ARCADIA post hoc! LV dysfunction is a treatment effect modifier of DOACs for #stroke prevention. (ie DOAC benefits only in ESUS with LV dysfunction) @StrokeAHA_ASA @StrokeAHA_ASA ahajournals.org/doi/10.1161/ST…